PatientPartner is a technology company.
PatientPartner has raised $4.0M across 1 funding round.
PatientPartner has raised $4.0M in total across 1 funding round.
PatientPartner is a health-tech startup that builds a mentor-driven patient engagement platform connecting patients with relatable mentors, doctors, and professionals who have experienced similar healthcare journeys. It serves pharmaceutical companies, med-tech firms, clinical research organizations (CROs), and other healthcare entities by solving key challenges in patient recruitment, retention, treatment adherence, and personalized support, delivering measurable ROI through boosted patient confidence (e.g., 71% success rate in prompting next steps) and proprietary sentiment insights.[1][2][3][4] With over 30,000 users, 500+ mentors, and thousands of engagements to date, the company recently raised $7-7.5M in funding to expand its platform, AI capabilities, and reach into new verticals, fueling strong growth momentum in a sector prioritizing personalized patient experiences.[2][3][4]
PatientPartner was founded in 2017 by George Kramb (CEO) and Patrick Frank (COO) in La Jolla, California, as a digital health platform aimed at enhancing patient experiences through peer mentorship and professional guidance.[3][4] The idea emerged from recognizing gaps in traditional patient support, where patients often lack emotional and practical advice during diagnoses, treatments, or procedures; the founders built a solution pairing patients with mentors who've undergone similar journeys, plus nearby in-network doctors.[1][3][4] Early traction came from partnerships with pharma and med-tech clients, facilitating thousands of mentor engagements and scaling to 30,000+ users with 500 mentors across healthcare fields, validated by recent $7-7.5M funding from investors like LionBird to accelerate innovation.[2][4]
PatientPartner stands out in patient engagement through these key strengths:
PatientPartner rides the wave of personalized healthcare and digital therapeutics, where pharma and med-tech shift from generic marketing to tech-driven, patient-centric models amid rising demands for adherence (e.g., post-diagnosis empowerment) and decentralized clinical trials (DCTs).[2][5] Timing is ideal as industry recognition grows for scalable mentorship—post-2024 funding signals momentum—fueled by market forces like AI advancements, regulatory pushes for patient outcomes, and pharma's need for real-time insights amid labor shortages in support roles.[1][2][4] It influences the ecosystem by setting benchmarks (e.g., 71% action rate), partnering with giants to transform recruitment/retention, and enabling data-driven decisions that lower costs and improve equity in care access.[2][4]
PatientPartner is poised to dominate patient engagement with AI-enhanced personalization, platform expansion into new populations/verticals, and deeper pharma integrations, targeting even higher ROI through refined algorithms and sentiment tools.[2][4][5] Trends like AI mentors, DCT growth, and value-based care will propel it, potentially scaling users exponentially while evolving influence from niche supporter to industry standard-setter. As a mentor-driven pioneer since 2017, it exemplifies how relatable human-AI hybrids revolutionize healthcare journeys, empowering patients and partners alike.[1][2]
PatientPartner has raised $4.0M in total across 1 funding round.
PatientPartner's investors include LionBird.
PatientPartner has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in September 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2024 | $4.0M Seed | LionBird |